ArsenalBio Launches With $85 Million Series A Financing to Advance New Paradigm to Discover and Develop Immune Cell Therapies

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/32Ai5Kl
via IFTTT